elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q34691408-F249CADA-7A1A-474C-ACC8-22DB1858FF6A
Q34691408-F249CADA-7A1A-474C-ACC8-22DB1858FF6A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34691408-F249CADA-7A1A-474C-ACC8-22DB1858FF6A
Insulin degludec improves glycaemic control with lower nocturnal hypoglycaemia risk than insulin glargine in basal-bolus treatment with mealtime insulin aspart in Type 1 diabetes (BEGIN(®) Basal-Bolus Type 1): 2-year results of a randomized clinical
P2860
Q34691408-F249CADA-7A1A-474C-ACC8-22DB1858FF6A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34691408-F249CADA-7A1A-474C-ACC8-22DB1858FF6A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
994ca7fc57bca20be84c01e21e997a9aa954e594
P2860
Design of the novel protraction mechanism of insulin degludec, an ultra-long-acting basal insulin.